Dose required to inhibit cell growth was determined against MDA-MB-231 cell line of human non-hormone dependent breast carcinoma
C(CCl)NC(=O)N(CCCl)N=O,7400
C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,80000
C1C2=C(C=C(C=C2)NC(=O)NCCCl)C3=CC=CC=C31,9000
C1CC2=C(C1)C=C(C=C2)NC(=O)NCCCl,10000
C1=CC=C2C=C(C=CC2=C1)NC(=O)NCCCl,6100
C1=CC(=CC=C1NC(=O)NCCCl)I,5700
CC(C)(C)C1=CC=C(C=C1)NC(=O)NCCCl,6200
CC(C)C1=CC=C(C=C1)NC(=O)NCCCl,2500
CCC(C)C1=CC=C(C=C1)NC(=O)NCCCl,3100
CC1=CC=C(C=C1)NC(=O)NCCCl,25000
CC1=CC(=CC(=C1)NC(=O)NCCCl)C,20000
CC1=CC(=CC=C1)NC(=O)NCCCl,60000
CC1=C(C=C(C=C1)NC(=O)NCCCl)C,7200
CC1=CC(=NC(=C1)NC(=O)NCCCl)C,50000
C1=CC2=C(C=C1NC(=O)NCCCl)C=NN2,76000
C1=CC(=CC(=C1)I)NC(=O)NCCCl,27000
CC(CNC(=O)NC1=CC=C(C=C1)C(C)(C)C)Cl,52000
CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C,131000
C1=CC=C(C=C1)NC(=O)NCCCl,140000
C1=CC=C2C(=C1)C=CC=C2NC(=O)NCCCl,150000
CC(C)CC1=CC=C(C=C1)NC(=O)NCCCl,24000
CCCCC1=CC=C(C=C1)NC(=O)NCCCl,19000
CCCC1=CC=C(C=C1)NC(=O)NCCCl,18000
CCC1=CC=C(C=C1)NC(=O)NCCCl,5000
CCCCCCCC1=CC=C(C=C1)NC(=O)NCCCl,30000
CCCCCCCCC1=CC=C(C=C1)NC(=O)NCCCl,33000
C1CCC(CC1)C2=CC=C(C=C2)NC(=O)NCCCl,44000
C1=CC(=CC=C1NC(=O)NCCCl)Cl,31000
C1=CC(=CC=C1NC(=O)NCCCl)Br,10000
CCCCCCC1=CC=C(C=C1)NC(=O)NCCCl,15000
CCCCCC1=CC=C(C=C1)NC(=O)NCCCl,12000
CC(C)CCC1=CC=C(C=C1)NC(=O)NCCCl,32000
CC(C)(C)CC1=CC=C(C=C1)NC(=O)NCCCl,34000
